Ju Wei, Yang Song, Feng Shenghu, Wang Qi, Liu Shunai, Xing Huichun, Xie Wen, Zhu Liying, Cheng Jun
Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, 8 East Jingshun Street, Chaoyang District, Beijing, 100015, China.
Center of Hepatology, Beijing Ditan Hospital, Capital Medical University, 8 East Jingshun Street, Chaoyang District, Beijing, 100015, China.
Virol J. 2015 Jul 25;12:109. doi: 10.1186/s12985-015-0341-1.
Hepatitis C virus (HCV) genotype and subtype are related to disease progression and response to antiviral therapy. Current HCV genotype and subtype distribution data, especially for genotypes 3 and 6, are limited in China. Our purpose was to investigate the current HCV genotype and subtype distributions in chronic hepatitis C patients in China.
Chronic hepatitis C patients (n = 1012) were enrolled, and demographic information and possible transmission risk factors were collected. Serum samples were subjected to reverse-transcription polymerase chain reaction, followed by direct DNA sequencing and phylogenetic analysis of the NS5B and core/E1 regions to determine HCV genotypes/subtypes. The geographical distributions of HCV genotypes/subtypes were analyzed. Demographic information and transmission risk factors were compared between different HCV genotypes/subtypes.
Four genotypes and seven subtypes of HCV were detected in 970 patients. Subtypes 1b, 2a, 3a, 6a, 3b, 6n, and 1a were detected at frequencies of 71.96%, 19.90%, 3.20%, 2.16%, 1.96%, 0.41%, and 0.41%, respectively. Genotypes 3 and 6 showed an increasingly wide geographic distribution over time. Patients with subtypes 1b and 2a were older than those with 3a, 3b, 6a, and 6n subtypes (p < 0.05 in all subtypes). More genotype 1 and 2 patients underwent blood transfusion than those with genotype 3 (all p < 0.05). More genotype 3 and 6 patients had a history of intravenous drug use than those with genotypes 1 and 2 (all p < 0.05).
Though subtypes 1b and 2a are still the most prevalent HCV subtypes in China, genotype 3 and 6 HCV infections have already spread nationwide from southern and western China.
丙型肝炎病毒(HCV)基因型和亚型与疾病进展及抗病毒治疗反应相关。目前中国HCV基因型和亚型分布数据有限,尤其是3型和6型。我们的目的是调查中国慢性丙型肝炎患者中当前HCV基因型和亚型的分布情况。
纳入1012例慢性丙型肝炎患者,收集人口统计学信息及可能的传播危险因素。血清样本进行逆转录聚合酶链反应,随后对NS5B和核心/E1区域进行直接DNA测序及系统发育分析以确定HCV基因型/亚型。分析HCV基因型/亚型的地理分布。比较不同HCV基因型/亚型之间的人口统计学信息和传播危险因素。
970例患者中检测到4种HCV基因型和7种亚型。1b、2a、3a、6a、3b、6n和1a亚型的检出频率分别为71.96%、19.90%、3.20%、2.16%、1.96%、0.41%和0.41%。随着时间推移,3型和6型基因型的地理分布越来越广。1b和2a亚型患者比3a、3b、6a和6n亚型患者年龄更大(所有亚型p<0.05)。1型和2型基因型患者输血史多于3型基因型患者(所有p<0.05)。3型和6型基因型患者静脉吸毒史多于1型和2型基因型患者(所有p<0.05)。
虽然1b和2a亚型仍是中国最常见的HCV亚型,但3型和6型HCV感染已从中国南部和西部蔓延至全国。